Waldenstrom macroglobulinemia - indolent disorder or slow killer?

Skip to the main content

Liječnički vjesnik, Vol. 142 No. Supp 5, 2020.

Meeting abstract

https://doi.org/10.26800/LV-142-supp5-19

Waldenstrom macroglobulinemia - indolent disorder or slow killer?

Iva Ljubas ; School of Medicine, University of Zagreb, Zagreb, Croatia
Ozana Miličević ; School of Medicine, University of Zagreb, Zagreb, Croatia
Inga Mandac Smoljanović ; Clinical Hospital Merkur, Department of Hematology, Zagreb, Croatia

Full text: english pdf 177 Kb

downloads: 360

APA 6th Edition

Ljubas, I., Miličević, O. & Mandac Smoljanović, I. (2020). Waldenstrom macroglobulinemia - indolent disorder or slow killer?. Liječnički vjesnik, 142 (Supp 5), 0-0. https://doi.org/10.26800/LV-142-supp5-19

MLA 8th Edition

Ljubas, Iva, et al. "Waldenstrom macroglobulinemia - indolent disorder or slow killer?." Liječnički vjesnik, vol. 142, no. Supp 5, 2020, pp. 0-0. https://doi.org/10.26800/LV-142-supp5-19. Accessed 18 Dec. 2024.

Chicago 17th Edition

Ljubas, Iva, Ozana Miličević and Inga Mandac Smoljanović. "Waldenstrom macroglobulinemia - indolent disorder or slow killer?." Liječnički vjesnik 142, no. Supp 5 (2020): 0-0. https://doi.org/10.26800/LV-142-supp5-19

Harvard

Ljubas, I., Miličević, O., and Mandac Smoljanović, I. (2020). 'Waldenstrom macroglobulinemia - indolent disorder or slow killer?', Liječnički vjesnik, 142(Supp 5), pp. 0-0. https://doi.org/10.26800/LV-142-supp5-19

Vancouver

Ljubas I, Miličević O, Mandac Smoljanović I. Waldenstrom macroglobulinemia - indolent disorder or slow killer?. Liječnički vjesnik [Internet]. 2020 [cited 2024 December 18];142(Supp 5). https://doi.org/10.26800/LV-142-supp5-19

IEEE

I. Ljubas, O. Miličević and I. Mandac Smoljanović, "Waldenstrom macroglobulinemia - indolent disorder or slow killer?", Liječnički vjesnik, vol.142, no. Supp 5, pp. 0-0, 2020. [Online]. https://doi.org/10.26800/LV-142-supp5-19

Abstract

Waldenström macroglobulinemia (WM) is an indolent (slow-growing) subtype of non-Hodgkin lymphoma that affects small lymphocytes. The risk of WM increases with age with median age at diagnosis of 63 years. Men are more likely than women to develop the WM. The overall incidence of WM is approximately five cases per one million persons per year

Keywords

lymphoma; hyperviscosity syndrome; macroglobulinemia

Hrčak ID:

251662

URI

https://hrcak.srce.hr/251662

Publication date:

27.1.2021.

Visits: 1.161 *